Abstract

Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed α1-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and are expected to have biological effects beyond their hemodynamic effects. To investigate the effects and mechanism of AR stimulation on the physiology of the whole body, various in vitro and in vivo experiments were conducted using the AR agonist midodrine, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide. The expression of various biomarkers involved in ATP production was estimated through Western blotting, reverse transcription polymerase chain reaction, oxygen consumption rate, enzyme-linked immunosorbent assay (ELISA), fluorescence staining, and Oil red O staining in several cell lines (skeletal muscle, cardiac muscle, liver, macrophage, vascular endothelial, and adipose cells). In spontaneously hypertensive rats, blood pressure, blood analysis, organ-specific biomarkers, and general biomolecules related to ATP production were measured with Western blot analysis, immunohistochemistry, ELISA, and echocardiography. Pharmacological activation of α1-adrenergic receptors in C2C12 skeletal muscle cells promoted mitochondrial oxidative phosphorylation and ATP production by increasing the expression of catabolic molecules, including PPARδ, AMPK, and PGC-1α, through cytosolic calcium signaling and increased GLUT4 expression, as seen in exercise. It also activated those energetic molecules and mitochondrial oxidative phosphorylation with cardiomyocytes, endothelial cells, adipocytes, macrophages, and hepatic cells and affected their relevant cell-specific biological functions. All of those effects occurred around 3 h (and peaked 6 h) after midodrine treatment. In spontaneously hypertensive rats, α1-adrenergic receptor stimulation affected mitochondrial oxidative phosphorylation and ATP production by activating PPARδ, AMPK, and PGC-1α and the relevant biologic functions of multiple organs, suggesting organ crosstalk. The treatment lowered blood pressure, fat and body weight, cholesterol levels, and inflammatory activity; increased ATP content and insulin sensitivity in skeletal muscles; and increased cardiac contractile function without exercise training. These results suggest that the activation of α1-adrenergic receptor stimulates energetic reprogramming via PPARδ that increases mitochondrial oxidative phosphorylation and has healthy and organ-specific biological effects in multiple organs, including skeletal muscle, beyond its vasomotion effect. In addition, the action mechanism of α1-adrenergic receptor may be mainly exerted via PPARδ.

Highlights

  • In the life of an organism, cellular bioenergetic needs are supplied through interconnected glycolysis in the cytoplasm and the tricarboxylic acid (TCA) cycle and oxidative phosphorylation in the mitochondria

  • The mitochondrial function of adenosine triphosphate (ATP) production is influenced by factors such as age, sex, nutritional status, and exercise performance, and we suggest that those factors program bioenergetic metabolism to be glycolysis or oxidative phosphorylation, which changes the metabolic function of multiple organs throughout the body

  • We conducted cell culture experiments to determine whether midodrine, a nonselective α1-adrenergic receptors (ARs) agonist, exerts independent effects on PPARδ protein and phosphorylated AMPK (p-AMPK) expression, and we evaluated the mitochondrial oxidative function and ATP production of skeletal muscle cells

Read more

Summary

Introduction

In the life of an organism, cellular bioenergetic needs are supplied through interconnected glycolysis in the cytoplasm and the tricarboxylic acid (TCA) cycle and oxidative phosphorylation in the mitochondria. In obesity and physical inactivity, which are frequently associated with mitochondrial dysfunction [10], accelerated glycolysis is expected to match the degree of mitochondrial dysfunction in oxidative phosphorylation, affecting the functions of organs throughout the body This pathophysiology could explain why metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyceridemia, hyper-low-density lipoprotein (LDL) cholesterol, hypo-high-density lipoprotein (HDL) cholesterol, insulin resistance, abnormal glucose tolerance, hypertension, vascular inflammation, atherosclerosis, and renal, liver, and heart diseases [11]. In this context, exercise is a way to modulate the metabolic pathway of ATP production and has a healthy effect by activating catabolic molecules such as PPARδ, AMPK, and PGC-1α, which stimulate mitochondrial oxidative phosphorylation [8] to change the plasticity of skeletal muscle. We used an animal model of metabolic syndrome without exercise training to investigate whether pharmacological α1-AR stimulation promotes the expression of genes for mitochondrial oxidative phosphorylation and causes biologic changes in multiple organs

Materials and Methods
Results
PPARδ β-Actin
PPARδ β-actin
P-AMPK
Conclusion
Conflicts of Interest
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.